Avidity Partners Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
+39,000
| New | +$1.84M | 0.37% | 48 |
|
|
2023
Q4 | – | Sell |
-777,172
| Closed | -$44.3M | – | 80 |
|
|
2023
Q3 | $44.3M | Buy |
777,172
+377,172
| +94% | +$21.5M | 1.78% | 19 |
|
|
2023
Q2 | $20.4M | Buy |
+400,000
| New | +$20.4M | 0.71% | 51 |
|
|
2022
Q2 | – | Sell |
-400,000
| Closed | -$4.44M | – | 92 |
|
|
2022
Q1 | $4.44M | Hold |
400,000
| – | – | 0.09% | 75 |
|
|
2021
Q4 | $3.96M | Hold |
400,000
| – | – | 0.08% | 85 |
|
|
2021
Q3 | $3.94M | Hold |
400,000
| – | – | 0.09% | 89 |
|
|
2021
Q2 | $4.14M | Hold |
400,000
| – | – | 0.11% | 98 |
|
|
2021
Q1 | $4.08M | Hold |
400,000
| – | – | 0.11% | 86 |
|
|
2020
Q4 | $4.55M | Buy |
+400,000
| New | +$4.55M | 0.15% | 81 |
|